Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 5

1.

Oral topotecan for refractory and relapsed neuroblastoma: a retrospective analysis.

Kramer K, Kushner BH, Cheung NK.

J Pediatr Hematol Oncol. 2003 Aug;25(8):601-5.

PMID:
12902911
2.

Topotecan in the treatment of relapsed small cell lung cancer patients with poor performance status.

Treat J, Huang CH, Lane SR, Levin J.

Oncologist. 2004;9(2):173-81. Review.

3.

Current and future strategies for relapsed neuroblastoma: challenges on the road to precision therapy.

Morgenstern DA, Baruchel S, Irwin MS.

J Pediatr Hematol Oncol. 2013 Jul;35(5):337-47. doi: 10.1097/MPH.0b013e318299d637. Review.

PMID:
23703550
4.

Investigational drugs in phase II clinical trials for the treatment of neuroblastoma.

Amoroso L, Haupt R, Garaventa A, Ponzoni M.

Expert Opin Investig Drugs. 2017 Nov;26(11):1281-1293. doi: 10.1080/13543784.2017.1380625. Epub 2017 Sep 26. Review.

PMID:
28906153
5.

Advances in emerging drugs for the treatment of neuroblastoma.

Berlanga P, CaƱete A, Castel V.

Expert Opin Emerg Drugs. 2017 Mar;22(1):63-75. doi: 10.1080/14728214.2017.1294159. Epub 2017 Feb 22. Review.

PMID:
28253830

Supplemental Content

Support Center